Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Cancer Immunology Research
|
August 23, 2015
Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent
C Bryce Johnson, Brian P Riesenberg, Bennett R May, et al.
Cancer Research
|
September 11, 2014
Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors
Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, et al.
The Journal of Clinical Investigation
|
January 27, 2026
Targeting Pim2 Improves Antitumor Immunity through Promoting Effector Function and Persistence of CD8 T cells
Yongxia Wu, Linlu Tian, Allison Pugel, et al.
The Journal of Clinical Investigation
|
May 22, 2018
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
Anusara Daenthanasanmak, Yongxia Wu, Supinya Iamsawat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 7, 2024
CD38-RyR2 axis-mediated signaling impedes CD8<sup>+</sup> T cell response to anti-PD1 therapy in cancer
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, et al.
Cancer Research
|
June 1, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, et al.
The Journal of Investigative Dermatology
|
December 25, 2013
A quantitative increase in regulatory T cells controls development of vitiligo
Shilpak Chatterjee, Jonathan M Eby, Amir A Al-Khami, et al.
Immunology
|
November 24, 2004
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells
Shikhar Mehrotra, Arvind Chhabra, Abolokita Chakraborty, et al.
Oncotarget
|
October 18, 2016
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
Pravin Kesarwani, Paramita Chakraborty, Radhika Gudi, et al.
Cancer Medicine
|
April 14, 2026
Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide
Jacqueline T Brown, Bassel Nazha, Anna C Ferreira, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Cancer Immunology Research
|
August 23, 2015
Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent
C Bryce Johnson, Brian P Riesenberg, Bennett R May, et al.
Cancer Research
|
September 11, 2014
Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors
Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, et al.
The Journal of Clinical Investigation
|
January 27, 2026
Targeting Pim2 Improves Antitumor Immunity through Promoting Effector Function and Persistence of CD8 T cells
Yongxia Wu, Linlu Tian, Allison Pugel, et al.
The Journal of Clinical Investigation
|
May 22, 2018
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
Anusara Daenthanasanmak, Yongxia Wu, Supinya Iamsawat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 7, 2024
CD38-RyR2 axis-mediated signaling impedes CD8<sup>+</sup> T cell response to anti-PD1 therapy in cancer
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, et al.
Cancer Research
|
June 1, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, et al.
The Journal of Investigative Dermatology
|
December 25, 2013
A quantitative increase in regulatory T cells controls development of vitiligo
Shilpak Chatterjee, Jonathan M Eby, Amir A Al-Khami, et al.
Immunology
|
November 24, 2004
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells
Shikhar Mehrotra, Arvind Chhabra, Abolokita Chakraborty, et al.
Oncotarget
|
October 18, 2016
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
Pravin Kesarwani, Paramita Chakraborty, Radhika Gudi, et al.
Cancer Medicine
|
April 14, 2026
Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide
Jacqueline T Brown, Bassel Nazha, Anna C Ferreira, et al.
Page
of 12